Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# AstraZeneca PLC (AZN)

AstraZeneca's stock is showing an upward trend, reaching a 52-week and all-time high, fueled by strong Q3 earnings and positive analyst outlooks. Recent social media buzz highlights strong free cash flow projections, despite ongoing discussions about past vaccine side effects.

### About AstraZeneca PLC
AstraZeneca PLC is a global pharmaceutical and biotechnology company.  
AstraZeneca PLC uses the ticker $AZN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- AstraZeneca PLC (AZN) creators hit XXX which is XXX% higher than it's daily average.
- AstraZeneca PLC (AZN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- AstraZeneca PLC (AZN) trading volume is up XXXXX% from the previous week.
- AstraZeneca PLC (AZN) social dominance is up XXXXXX% from the previous X months.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$azn/time-series/close.tsv)  
AstraZeneca's stock price is experiencing an upward trend, hitting a 52-week and all-time high, driven by strong Q3 earnings, positive analyst outlooks, and recent social media buzz highlighting strong free cash flow projections, despite ongoing discussions about past vaccine side effects.  

24-Hour: -XXXX%
7-Day: -XXXX%
30-Day: XXXX%

1-Year High: $XXXXX on 2025-11-26  
1-Year Low: $XXXXX on 2024-12-19  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$azn/time-series/alt_rank.tsv)  
AstraZeneca PLC (AZN) is currently AltRank #228 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -X  
X Month: XXX -XXX  
X Months: XXX +158  
X Year: XXX -XX  
1-Year High: XXXXX on 2025-05-08  
1-Year Low: X on 2025-07-29  
  
  
### Galaxy Score: XX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$azn/time-series/galaxy_score.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX +1  
X Month: XX +2  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2025-02-12  
1-Year Low: XX on 2025-06-29  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$azn/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXXXXX -XX%  
X Month: XXXXXXXXX +48%  
X Months: XXXXXXXXXX +165%  
X Year: XXXXXXXXXX +43%  
1-Year High: XXXXXXXXX on 2025-11-01  
1-Year Low: XXXXX on 2025-01-26  

Engagements by network (24h):
News: XXX
Reddit: XXXXX
TikTok: XXXXXX
X: XXXXXX
YouTube: XXXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$azn/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +63%  
X Year: XXXXXX -XXXX%  
1-Year High: XXXXX on 2025-03-13  
1-Year Low: XX on 2025-01-27  

Mentions by network (24h):
News: XX
Reddit: XXX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$azn/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning AstraZeneca PLC (AZN) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXXXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +87%  
X Year: XXXXXX -XX%  
1-Year High: XXX on 2025-11-10  
1-Year Low: XX on 2025-01-27  

The most influential creators that mention AstraZeneca PLC in the last XX hours

| Creator                                                    | Rank | Followers | Posts | Engagements |
| -------                                                    | ---- | --------- | ----- | ----------- |
| [@astrazenecagermany](/creator/youtube/astrazenecagermany) | X    | XXX       | X     | XXXXXX      |
| [@WallStSai](/creator/twitter/WallStSai)                   | X    | XXXXX     | X     | XXXXX       |
| [@JacobPlieth](/creator/twitter/JacobPlieth)               | X    | XXXXXX    | X     | XXXXX       |
| [@thepharmabts](/creator/tiktok/thepharmabts)              | X    | XXXXX     | X     | XXXXX       |
| [@BIOTECHSCANNER](/creator/twitter/BIOTECHSCANNER)         | X    | XXXXX     | X     | XXXXX       |
| [@AfzalValli](/creator/twitter/AfzalValli)                 | X    | XXXXXX    | XX    | XXXXX       |
| [@grok](/creator/twitter/grok)                             | X    | XXXXXXXXX | XX    | XXXXX       |
| [@lyrikstreet](/creator/tiktok/lyrikstreet)                | X    |           | X     | XXX         |
| [@BowTiedBiotech](/creator/twitter/BowTiedBiotech)         | X    | XXXXXX    | X     | XXX         |
| [@fwpharma](/creator/twitter/fwpharma)                     | XX   | XXXXXX    | X     | XXX         |

[View More](/list/creators/$azn/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$azn/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% +4%  
X Months: XX% +12%  
X Year: XX% +5%  
1-Year High: XX% on 2025-03-19  
1-Year Low: XX% on 2025-11-01  

Most Supportive Themes:
- Oncology and Biopharma Prospects: (25%) Analysts have upgraded their outlook on AstraZeneca's performance in the oncology and biopharmaceutical sectors.
- Clinical Trial Successes: (20%) Positive outcomes from clinical trials, especially in areas like breast cancer treatment, are contributing to a favorable sentiment.
  
Most Critical Themes:
- UK Investment Concerns: (40%) Concerns exist regarding AstraZeneca's investments in the UK and potential changes to stock market listings, creating uncertainty.
- COVID-19 Vaccine Side Effects: (35%) Past acknowledgments of rare side effects associated with the COVID-19 vaccine continue to be a subject of discussion and criticism.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$azn/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.072%  
X Month: XXXX% +0.197%  
X Months: XXXX% +0.249%  
X Year: XXXX% +0.196%  
1-Year High: XXXXX% on 2025-03-13  
1-Year Low: XXXXX% on 2025-09-21  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$azn/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-03-12  
1-Year Low: XXXXX% on 2025-07-21  
  
  
### Market Cap: $XXXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$azn/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$azn/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXXX -$0.86%  
X Month: $XXXXXXXXXXXXXXX +$6.20%  
X Months: $XXXXXXXXXXXXXXX +$20%  
X Year: $XXXXXXXXXXXXXXX +$31%  
1-Year High: $XXXXXXXXXXXXXXX on 2025-11-26  
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19  

### Top AstraZeneca PLC News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"US FDA launches fresh safety scrutiny of approved RSV therapies for infants CNN"  
[News Link](https://www.cnn.com/2025/12/09/health/fda-rsv-vaccine-review) [@CNN](/creator/x/CNN) 2025-12-09T22:02Z 60.8M followers, XXX engagements


"Woman XX died from complications due to AstraZeneca Covid jab coroner rules Daily Mail Online"  
[News Link](https://www.dailymail.co.uk/news/article-10906969/Woman-38-died-complications-AstraZeneca-Covid-jab-coroner-rules.html) [@DailyMail](/creator/x/DailyMail) 2025-12-09T17:32Z 228.6M followers, X engagements


"A data-driven machine learning framework to predict side effects of AstraZeneca and sinopharm COVID-19 vaccines Scientific Reports"  
[News Link](https://www.nature.com/articles/s41598-025-24248-5) [@NaturePortfolio](/creator/x/NaturePortfolio) 2025-11-19T13:10Z 228.6M followers, XX engagements


"Queensland's Chief Health Officer rejects Prime Minister's comments on AstraZeneca's COVID-19 vaccine for under-40s - ABC News"  
[News Link](https://www.abc.net.au/news/2021-06-30/qld-cho-rejects-morrisons-astrazeneca-comments-covid-vaccine/100256022) [@ABCaustralia](/creator/x/ABCaustralia) 2025-11-16T01:21Z 228.6M followers, XX engagements



### Top AstraZeneca PLC Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"@WallStSai If deal done for $ABVX IMO will be either $AZN ( part of CEO vision to $XX B ) or $MRK ( Dean Li making a niche in IBD ) But why will they cancel talk while negotiating unless they are getting several offers and there is bid war going on"  
[X Link](https://x.com/bioinvestor24/status/1998553533260640765) [@bioinvestor24](/creator/x/bioinvestor24) 2025-12-10T00:41Z 4866 followers, XXX engagements


"No public statements found from these companies/CEOs on fenbendazole or ivermectin for cancer (verified via official sites 2023-2025). They focus on patented oncology drugs like: - Merck: Keytruda - BMS: Opdivo - AstraZeneca: Tagrisso Imfinzi (Vaxzevria pushed for COVID with noted clot risks) - Pfizer: Ibrance Xtandi - Roche: Tecentriq - Novartis: Kisqali Pluvicto These generate high revenues per 2025 reports"  
[X Link](https://x.com/grok/status/1998537770898534752) [@grok](/creator/x/grok) 2025-12-09T23:38Z 6.8M followers, XXX engagements


"Major pharma companies with high oncology revenue (e.g. from drugs like Keytruda Opdivo) that could face revenue impacts if low-cost alternatives prove effective include: - Merck & Co.: Robert M. Davis (CEO) - Bristol-Myers Squibb: Christopher Boerner (CEO) - AstraZeneca: Pascal Soriot (CEO) - Pfizer: Albert Bourla (CEO) - Roche: Thomas Schinecker (CEO) - Novartis: Vasant Narasimhan (CEO) Based on 2025 reports from PharmaShots and Fierce Pharma"  
[X Link](https://x.com/grok/status/1998531884796838038) [@grok](/creator/x/grok) 2025-12-09T23:15Z 6.8M followers, XXX engagements


"Largecaps ($20-200B) - Dec X Gainers Losers $MOB +18% $FERG -X% $UL +16% $AZO -XXX% $PSNY +9.4% $ALAB -XXX% $ARES +7.3% $CRDO -XXX% $TPG +6.1% $BIDU -XXX% $SATS +6% $ROL -XXX% $CRCL +5.9% $ORLY -XXX% $NEM +5.7% $NBIS -XXX% $LITE +5.2% $VRT -XXX% $CRWV +5.1% $UBER -XXX% $APO +4.7% $ALNY -XXX% $GFI +4.7% $MRVL -XXX% $KKR +4.3% $VRSN -XXX% $WPM +4.1% $TKO -XXX% $OWL +4.1% $VEEV -2.9%"  
[X Link](https://x.com/MarketCap_Live/status/1998528602921685171) [@MarketCap_Live](/creator/x/MarketCap_Live) 2025-12-09T23:02Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AstraZeneca PLC (AZN)

AstraZeneca's stock is showing an upward trend, reaching a 52-week and all-time high, fueled by strong Q3 earnings and positive analyst outlooks. Recent social media buzz highlights strong free cash flow projections, despite ongoing discussions about past vaccine side effects.

About AstraZeneca PLC

AstraZeneca PLC is a global pharmaceutical and biotechnology company.
AstraZeneca PLC uses the ticker $AZN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • AstraZeneca PLC (AZN) creators hit XXX which is XXX% higher than it's daily average.
  • AstraZeneca PLC (AZN) social dominance hit XXXXXX which is XXX% higher than it's daily average.
  • AstraZeneca PLC (AZN) trading volume is up XXXXX% from the previous week.
  • AstraZeneca PLC (AZN) social dominance is up XXXXXX% from the previous X months.

Price: $XXXXX

Price Line Chart
Price 24-Hour Time-Series Raw Data
AstraZeneca's stock price is experiencing an upward trend, hitting a 52-week and all-time high, driven by strong Q3 earnings, positive analyst outlooks, and recent social media buzz highlighting strong free cash flow projections, despite ongoing discussions about past vaccine side effects.

24-Hour: -XXXX% 7-Day: -XXXX% 30-Day: XXXX%

1-Year High: $XXXXX on 2025-11-26
1-Year Low: $XXXXX on 2024-12-19

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
AstraZeneca PLC (AZN) is currently AltRank #228 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -X
X Month: XXX -XXX
X Months: XXX +158
X Year: XXX -XX
1-Year High: XXXXX on 2025-05-08
1-Year Low: X on 2025-07-29

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +1
X Month: XX +2
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-02-12
1-Year Low: XX on 2025-06-29

Engagements: XXXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXX
X Week: XXXXXXXXX -XX%
X Month: XXXXXXXXX +48%
X Months: XXXXXXXXXX +165%
X Year: XXXXXXXXXX +43%
1-Year High: XXXXXXXXX on 2025-11-01
1-Year Low: XXXXX on 2025-01-26

Engagements by network (24h): News: XXX Reddit: XXXXX TikTok: XXXXXX X: XXXXXX YouTube: XXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +63%
X Year: XXXXXX -XXXX%
1-Year High: XXXXX on 2025-03-13
1-Year Low: XX on 2025-01-27

Mentions by network (24h): News: XX Reddit: XXX TikTok: XXX X: XXXXX YouTube: XXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning AstraZeneca PLC (AZN) in the last XX hours which is up XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXXXX -XX%
X Month: XXXXX -XX%
X Months: XXXXXX +87%
X Year: XXXXXX -XX%
1-Year High: XXX on 2025-11-10
1-Year Low: XX on 2025-01-27

The most influential creators that mention AstraZeneca PLC in the last XX hours

Creator Rank Followers Posts Engagements
@astrazenecagermany X XXX X XXXXXX
@WallStSai X XXXXX X XXXXX
@JacobPlieth X XXXXXX X XXXXX
@thepharmabts X XXXXX X XXXXX
@BIOTECHSCANNER X XXXXX X XXXXX
@AfzalValli X XXXXXX XX XXXXX
@grok X XXXXXXXXX XX XXXXX
@lyrikstreet X X XXX
@BowTiedBiotech X XXXXXX X XXX
@fwpharma XX XXXXXX X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% +4%
X Months: XX% +12%
X Year: XX% +5%
1-Year High: XX% on 2025-03-19
1-Year Low: XX% on 2025-11-01

Most Supportive Themes:

  • Oncology and Biopharma Prospects: (25%) Analysts have upgraded their outlook on AstraZeneca's performance in the oncology and biopharmaceutical sectors.
  • Clinical Trial Successes: (20%) Positive outcomes from clinical trials, especially in areas like breast cancer treatment, are contributing to a favorable sentiment.

Most Critical Themes:

  • UK Investment Concerns: (40%) Concerns exist regarding AstraZeneca's investments in the UK and potential changes to stock market listings, creating uncertainty.
  • COVID-19 Vaccine Side Effects: (35%) Past acknowledgments of rare side effects associated with the COVID-19 vaccine continue to be a subject of discussion and criticism.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.072%
X Month: XXXX% +0.197%
X Months: XXXX% +0.249%
X Year: XXXX% +0.196%
1-Year High: XXXXX% on 2025-03-13
1-Year Low: XXXXX% on 2025-09-21

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-12
1-Year Low: XXXXX% on 2025-07-21

Market Cap: $XXXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXXX -$0.86%
X Month: $XXXXXXXXXXXXXXX +$6.20%
X Months: $XXXXXXXXXXXXXXX +$20%
X Year: $XXXXXXXXXXXXXXX +$31%
1-Year High: $XXXXXXXXXXXXXXX on 2025-11-26
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-19

Top AstraZeneca PLC News

Top news links shared on social in the last XX hours

Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.

"US FDA launches fresh safety scrutiny of approved RSV therapies for infants CNN"
News Link @CNN 2025-12-09T22:02Z 60.8M followers, XXX engagements

"Woman XX died from complications due to AstraZeneca Covid jab coroner rules Daily Mail Online"
News Link @DailyMail 2025-12-09T17:32Z 228.6M followers, X engagements

"A data-driven machine learning framework to predict side effects of AstraZeneca and sinopharm COVID-19 vaccines Scientific Reports"
News Link @NaturePortfolio 2025-11-19T13:10Z 228.6M followers, XX engagements

"Queensland's Chief Health Officer rejects Prime Minister's comments on AstraZeneca's COVID-19 vaccine for under-40s - ABC News"
News Link @ABCaustralia 2025-11-16T01:21Z 228.6M followers, XX engagements

Top AstraZeneca PLC Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"@WallStSai If deal done for $ABVX IMO will be either $AZN ( part of CEO vision to $XX B ) or $MRK ( Dean Li making a niche in IBD ) But why will they cancel talk while negotiating unless they are getting several offers and there is bid war going on"
X Link @bioinvestor24 2025-12-10T00:41Z 4866 followers, XXX engagements

"No public statements found from these companies/CEOs on fenbendazole or ivermectin for cancer (verified via official sites 2023-2025). They focus on patented oncology drugs like: - Merck: Keytruda - BMS: Opdivo - AstraZeneca: Tagrisso Imfinzi (Vaxzevria pushed for COVID with noted clot risks) - Pfizer: Ibrance Xtandi - Roche: Tecentriq - Novartis: Kisqali Pluvicto These generate high revenues per 2025 reports"
X Link @grok 2025-12-09T23:38Z 6.8M followers, XXX engagements

"Major pharma companies with high oncology revenue (e.g. from drugs like Keytruda Opdivo) that could face revenue impacts if low-cost alternatives prove effective include: - Merck & Co.: Robert M. Davis (CEO) - Bristol-Myers Squibb: Christopher Boerner (CEO) - AstraZeneca: Pascal Soriot (CEO) - Pfizer: Albert Bourla (CEO) - Roche: Thomas Schinecker (CEO) - Novartis: Vasant Narasimhan (CEO) Based on 2025 reports from PharmaShots and Fierce Pharma"
X Link @grok 2025-12-09T23:15Z 6.8M followers, XXX engagements

"Largecaps ($20-200B) - Dec X Gainers Losers $MOB +18% $FERG -X% $UL +16% $AZO -XXX% $PSNY +9.4% $ALAB -XXX% $ARES +7.3% $CRDO -XXX% $TPG +6.1% $BIDU -XXX% $SATS +6% $ROL -XXX% $CRCL +5.9% $ORLY -XXX% $NEM +5.7% $NBIS -XXX% $LITE +5.2% $VRT -XXX% $CRWV +5.1% $UBER -XXX% $APO +4.7% $ALNY -XXX% $GFI +4.7% $MRVL -XXX% $KKR +4.3% $VRSN -XXX% $WPM +4.1% $TKO -XXX% $OWL +4.1% $VEEV -2.9%"
X Link @MarketCap_Live 2025-12-09T23:02Z XXX followers, XXX engagements

AstraZeneca PLC (AZN)
/topic/$azn